[Rapamycin effect on senescence and autophagy processes in human cell lines]

Area of Science:

• Cellular biology
• Molecular oncology
• Pharmacology

Background:

• Autophagy and senescence are cellular processes that initially prevent tumor development by halting damaged cell proliferation.
• Autophagy is a survival mechanism during stress, while senescence involves non-proliferating cells that secrete growth factors.
• Rapamycin inhibits the mTOR pathway, crucial for cell metabolism and protein synthesis, and normally suppresses autophagy.

Purpose of the Study:

• To investigate the effects of rapamycin on autophagy and senescence in normal and transformed cell lines.
• To elucidate the role of the oncogene RAC3 in autophagy regulation.
• To understand the molecular mechanisms underlying rapamycin's anti-tumor potential.

Main Methods:

• Treatment of normal and transformed cell lines with varying concentrations of rapamycin.
• Analysis of autophagy induction and senescence promotion.
• Investigation of RAC3 oncogene expression and its impact on autophagy.

Main Results:

• Low rapamycin concentrations induced senescence in normal cells.
• High rapamycin concentrations induced autophagy in transformed cells.
• The oncogene RAC3 was found to inhibit autophagy and its expression was reduced by rapamycin.

Conclusions:

• Rapamycin exhibits distinct effects on cell fate depending on concentration and cell type.
• Understanding these differential effects is key to optimizing rapamycin for cancer therapy.
• Targeting RAC3 may be a viable strategy in rapamycin-based anti-cancer treatments.